news Novel inhibitor developed to combat HER2-positive breast cancer 26 June 2024 | By Drug Target Review The inhibitor, HVH-2930, effectively induced apoptosis in breast cancer cells without initiating the heat shock response.
news Targeting drug resistance in HER2-positive breast cancer models 30 May 2024 | By Drug Target Review Researchers discovered that HER2-positive breast cancer drugs must target both HER2 and EGFR receptors to eradicate disease.
news P47 suppresses metastasis of HER2-positive breast cancer 12 March 2024 | By Drug Target Review Results from an in vivo CRISPR knockout screen, targeting genes involved in autophagy, could lead to new therapies.